drugset / Trial / NCT04267770

Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion

NCT04267770

Completed 17 enrolled Imperial College London
RandomizedParallel-groupOpen-labelSupportive care

Summary

Randomised controlled trial to contribute to the evidence base for the optimal initial insulin profile for adults with type 1 diabetes commencing insulin pump therapy.

Timeline

Start
2018-04-10
Primary completion
2018-11-09
Completion
2018-11-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Subcutaneous